Different evasion strategies in multiple myeloma

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Multiple myeloma (MM) is a challenging hematologic malignancy characterized by immune escape and drug resistance.
• Current treatments like immunomodulatory drugs (IMiDS), protease inhibitors (PI), monoclonal antibodies (mAb), and hematopoietic stem cell transplantation (HSCT) have limitations in achieving a cure.
• MM cells employ strategies such as uncontrolled proliferation, genetic mutations, and tumor antigen deletion for immune evasion.

Purpose of the Study:

• To provide an integrated overview of multiple myeloma's immune evasion and drug resistance mechanisms.
• To highlight the role of intrinsic and extrinsic factors, including the microbiota, in MM progression.
• To offer a theoretical basis for designing novel immunotherapies and drug combinations against MM.

Main Methods:

• This review synthesizes current literature on multiple myeloma's evasion strategies.
• It examines intrinsic cellular mechanisms and extrinsic factors influencing immune escape.
• The role of the microbiota in multiple myeloma pathogenesis and treatment resistance is explored.

Main Results:

• Multiple myeloma utilizes diverse strategies to evade host immune surveillance and resist therapies.
• Genetic alterations and deletions of tumor antigens contribute to immune escape.
• The gut microbiota is increasingly recognized for its influence on MM immune evasion and drug resistance.

Conclusions:

• A comprehensive understanding of MM's multifaceted evasion mechanisms is essential for therapeutic advancement.
• Targeting these evasion strategies, including the microbiota, may lead to more effective treatments.
• Developing specific immunotherapies and drug combinations holds promise for improving outcomes and survival in multiple myeloma patients.